Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Eight babies born free of hereditary disease using DNA from three people.

A woman supporting a baby's feet

How It Works

The technique involves combining DNA from the biological parents with healthy mitochondria from a female donor. The result: babies inherit 99.9% of their DNA from their parents, and 0.1% from the donor, effectively stopping the transmission of defective mitochondria.

Lifesaving Potential

Mitochondrial disorders affect around 1 in 5,000 births and can lead to severe disability or early death. This new method offers hope for families with a history of the disease and could help 20–30 families each year.

Ethical and Scientific First

The UK is the first country to legalise mitochondrial donation, following a 2015 parliamentary vote. Scientists say this success was only possible through collaboration between UK researchers, clinicians, lawmakers, and the NHS.

 

 

Read the full story on the Nuffield Department of Women's & Reproductive Health website.

 

Similar stories

Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.